Alector Inc (ALEC)
4.91
-0.22
(-4.20%)
USD |
NASDAQ |
Nov 14, 16:00
4.905
0.00 (0.00%)
After-Hours: 20:00
Alector Research and Development Expense (Quarterly): 48.00M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 48.00M |
June 30, 2024 | 46.31M |
March 31, 2024 | 45.17M |
December 31, 2023 | 47.72M |
September 30, 2023 | 46.33M |
June 30, 2023 | 46.18M |
March 31, 2023 | 51.89M |
December 31, 2022 | 54.49M |
September 30, 2022 | 48.35M |
June 30, 2022 | 54.53M |
March 31, 2022 | 53.04M |
December 31, 2021 | 52.79M |
September 30, 2021 | 43.07M |
June 30, 2021 | 47.82M |
Date | Value |
---|---|
March 31, 2021 | 45.73M |
December 31, 2020 | 44.38M |
September 30, 2020 | 43.82M |
June 30, 2020 | 34.06M |
March 31, 2020 | 34.60M |
December 31, 2019 | 25.76M |
September 30, 2019 | 28.52M |
June 30, 2019 | 25.64M |
March 31, 2019 | 20.61M |
December 31, 2018 | 24.10M |
September 30, 2018 | 20.39M |
June 30, 2018 | 16.82M |
March 31, 2018 | 11.72M |
December 31, 2017 | 10.84M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
25.76M
Minimum
Dec 2019
54.53M
Maximum
Jun 2022
45.70M
Average
46.32M
Median
Research and Development Expense (Quarterly) Benchmarks
Precision BioSciences Inc | 13.08M |
NovaBay Pharmaceuticals Inc | 0.004M |
Palatin Technologies Inc | 4.672M |
iBio Inc | 1.14M |
Theriva Biologics Inc | 2.953M |